Search company, investor...


Founded Year



Growth Equity | Dead

Total Raised


Last Raised


About eSCeTe

Provider of high purity single crystals in all technically possible dopings and forms. The company provides a range of high purity single crystals such as magnesium oxide, sapphire, and strontium titanate. The company's crystals have applications in superconducting electronic devices, high brightness light emitting diodes (LED) and blue spectrum laser diodes, infrared detectors, saw devices, optical isolators, active and passive optical components, resonators and oscillators, scintillator crystals, and semiconductors.

Headquarters Location

Ir. Schiffstraat 220

Enschede, 7500 DW,


31 534 356 146

Missing: eSCeTe's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: eSCeTe's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

eSCeTe Frequently Asked Questions (FAQ)

  • When was eSCeTe founded?

    eSCeTe was founded in 1992.

  • Where is eSCeTe's headquarters?

    eSCeTe's headquarters is located at Ir. Schiffstraat 220, Enschede.

  • What is eSCeTe's latest funding round?

    eSCeTe's latest funding round is Growth Equity.

  • How much did eSCeTe raise?

    eSCeTe raised a total of $570K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.